Restricted ventilation or continuous operation beyond rated duty cycles.
| Phase | Status | Key Observations | |-------|--------|------------------| | In vitro | Complete | Selective killing of antigen-positive cell lines; minimal effect on normal cells | | In vivo (xenograft models) | Complete | Tumor regression at well-tolerated doses | | Phase 1 (dose escalation) | [Ongoing / Planned] | Evaluating safety, MTD, PK/PD, and preliminary efficacy |
Here is helpful, informative content about , structured for clarity and utility. This content is written for a technical or clinical audience (e.g., researchers, biotech professionals, or advanced students) and can be adapted for a website, data sheet, or internal document.
Restricted ventilation or continuous operation beyond rated duty cycles.
| Phase | Status | Key Observations | |-------|--------|------------------| | In vitro | Complete | Selective killing of antigen-positive cell lines; minimal effect on normal cells | | In vivo (xenograft models) | Complete | Tumor regression at well-tolerated doses | | Phase 1 (dose escalation) | [Ongoing / Planned] | Evaluating safety, MTD, PK/PD, and preliminary efficacy |
Here is helpful, informative content about , structured for clarity and utility. This content is written for a technical or clinical audience (e.g., researchers, biotech professionals, or advanced students) and can be adapted for a website, data sheet, or internal document.
